Mural Oncology shareholders re-elect all six director nominees at 2025 AGM

Mural Oncology plc

Director nominees Cuss, Golumbeski, Hickey, Jackson, Loew, and Minegishi each received >5.7M votes for; all re-elected.
Shareholders ratified PricewaterhouseCoopers LLP as independent auditor for FY2025 with 11.9M votes for, 190K against.
Broker non-votes of 5.66M shares were present for director elections.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.